Sign in
4

Changes in Ownership

Lexaria Bioscience Corp. Filed Acc 0001348362-20-000005

Options or other derivatives

  • Chief Executive Officer disposed of 700,000 shares (other)

From the SEC's structured data for this filing

Trades in this filing

BUNKA CHRISTOPHER · Chief Executive Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2020-03-23 Other disposition : show line 1 in the form stock options −700,000 0 D
Loading xslF345X03/primary_doc.xml…